Hostname: page-component-76fb5796d-22dnz Total loading time: 0 Render date: 2024-04-27T01:54:00.972Z Has data issue: false hasContentIssue false
  • English
  • Français

Attempts to induce resistance to Schistosoma mansoni and S. haematobium in Kenyan baboons (Papio anubis) using non-specific immunostimulants

Published online by Cambridge University Press:  06 April 2009

R. F. Sturrock ,
B. J. Cottrell ,
A. A. F. Mahmoud ,
L. Chedid  and
R. Kimani
R. F. Sturrock
Affiliation:
Department of Medical Helminthology, London School of Hygiene and Tropical Medicine, Keppel Street (Gower Street), London WC1E 7HT
B. J. Cottrell
Affiliation:
Department of Medical Helminthology, London School of Hygiene and Tropical Medicine, Keppel Street (Gower Street), London WC1E 7HT
A. A. F. Mahmoud
Affiliation:
Department of Medical Helminthology, London School of Hygiene and Tropical Medicine, Keppel Street (Gower Street), London WC1E 7HT
L. Chedid
Affiliation:
Department of Medical Helminthology, London School of Hygiene and Tropical Medicine, Keppel Street (Gower Street), London WC1E 7HT
R. Kimani
Affiliation:
Department of Medical Helminthology, London School of Hygiene and Tropical Medicine, Keppel Street (Gower Street), London WC1E 7HT
Get access Rights & Permissions [Opens in a new window]

Extract

Non-specific immunostimulants were used in an attempt to protect baboons from infection by schistosomes. Subcutaneous vaccination with cord factor (4·50 mg) and muramyl dipeptide (4·56 mg) 6 days before percutaneous exposure to 3000 Schistosoma haematobium cercariae/baboon (c.p.b.) failed to protect naive baboons: baboons with a 7-month-old, 5000 c.p.b. S. haenzatobium primary infection had developed too strong a natural immunity to detect any protection attributable to vaccination. Subcutaneous vaccination with 0·4 ml of Bacillus Calmette-Guerin (BOG, 1–8 x 108 colony forming units7sol;ml) 4 days before exposure to 1000 c.p.b. S. mansoni gave a significant (38%) reduction in worm load compared with controls. However, vaccination with 0·8 (intramuscular) and 0·2 (intradermal) ml of BOG 11 days before exposure to S. mansoni 800 c.p.b. did not protect naive baboons, nor did it significantly reduce challenge worm recovery from baboons with a 13-week-old, 500 c.p.b. S. mansoni primary infection. Obvious pathology was seen at the site of vaccination in the first but not the second BCG experiment. These results partly support the findings in mice that non-specific macrophage and monocyte activators give partial protection against schistosome infections but they also illustrate that rodents and primates do not necessarily react identically. Hence, findings from rodent models should be extrapolated to man with some caution.

Type
Research Article
Information
Parasitology , Volume 90 , Issue 1 , February 1985 , pp. 101 - 110
Copyright
Copyright © Cambridge University Press 1985

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Bout, D., Dupas, H., Carlier, Y., Afchaln, D. & Capron, A. (1977). Protection of mice against Schistosoma mansoni with BCG. International Research Communication System Medical Science 5, 47.Google Scholar
Butterworth, A. E., Sturrock, R. F., Houba, V. & Taylor, R. (1976). Schistosoma mansoni in baboons: antibody-dependent cell-mediated damage to 51Cr-labelled schistosomula. Clinical and Experimental Immunology 25, 95–102.Google ScholarPubMed
Capron, M. & Lesoin, M.-A. (1969). Role protecteur du B.C.G. dans la schistosomiase expérimentale à S. mansoni. Comptes Rendus us de l'Academie des Sciences (D) (Paris) 269, 2110–12.Google ScholarPubMed
Civil, R. H. & Marmoud, A. A. F. (1977). A role for thymocytes in BCG-induced resistance to Schistosoma mansoni infection. Federation Proceedings 36, 1057.Google Scholar
Civil, R. H., Warren, K. S. & Mahmoud, A. A. F. (1978). Conditions for Bacille Calmette-Guerin induced resistance to infection with Schistosoma mansoni in mice. Journal of Infectious Diseases 137, 550–5.Google Scholar
Damian, R. T., Greene, N. D., Meyer, K. F., Cheever, A. N., Hubbard, W. J., Hawes, M. E. & Clark, J. D. (1976). Schistosoma mansoni in baboons. III. The course and characteristics of infection with additional observations on immunity. American Journal of Tropical Medicine and Hygiene 25, 299–306.CrossRefGoogle ScholarPubMed
Ellner, J. J. & Mahmoud, A. A. F. (1979). Killing of schistosomula of Schistosoma mansoni by normal human monocytes. Journal of Immunology 123, 949–51.Google Scholar
Mahmoud, A. A. F., Civil, R. H., Lederer, E. & Chedid, L. (1977). Enhancement of resistance against a multicellular helminth (Schistosoma mansoni) by cord factor (CF) (Abstract). Clinical Research 25, 380A.Google Scholar
Mahmoud, A. A. F., Peters, P. A. S., Civil, R. H. & Remington, J. S. (1979). In vitro killing of Schistosoma mansoni by BCG, and C. parvum-activated macrophages. Journal of Immunology 122, 1655–7.CrossRefGoogle ScholarPubMed
Moore, P. G., Shirley, E. A. & Edwards, D. E. (1972). Standard Statistical Calculations, pp. 123. London: Sir Isaac Pitman & Sons.Google Scholar
Olds, G. R., Chedid, L., Lederer, E. & Mahmoud, A. A. F. (1980). Induction of resistance to Schistosoma mansoni by natural cord factor and synthetic lower homologues. Journal of Infectious Diseases 141, 473–8.CrossRefGoogle ScholarPubMed
Peters, P. A. S., Mahmoud, A. A. F., Warren, K. S., Ouma, J. H. & Sionook, T. K. A. (1976). Field studies of a rapid, accurate means of quantifying Schistosoma haematobium eggs in urine samples. Bulletin of the World Health Organization 54, 159–62.Google Scholar
Snedecor, G. W. & Cochran, W. G. (1967). Statistical Methods (6th Edn.), pp. 593. Ames, Iowa: State University Press.Google Scholar
Stek, M., Minard, P., Dean, D. A. & Hall, J. E. (1981). Immunization of baboons with Schistosoma mansoni cercariae attenuated by gamma irradiation. Science 212, 1518–20.CrossRefGoogle Scholar
Sturrock, R. F., Butterworth, A. E. & Houba, V. (1976). Schistosoma mansoni in the baboon (Papioanubis): parasitological responses of Kenyan baboons to different exposures of a local parasite strain. Parasitology 75, 239–52.Google Scholar
Stureock, R. F., Butterworth, A. E., Houba, V., Karamsadkar, S. D. & Kimani, R. (1978). Schistosolna mansoni in the Kenyan baboon (Papio anubis): the development and predictability of resistance to homologous challenge. Transactions of the Royal Society of Tropical Medicine and Hygiene 72, 251–61.CrossRefGoogle Scholar
Sturrock, R. F., Butterworth, A. E., Karamsadkar, S. D., Kimani, R., Imbuga, M. & Houba, V. (1977). Eosinophilia in Kenyan baboons (Papio anubis) induced by Trichinella spiralis and Schistosoma mansoni. Parasitology 75, 89–100.Google Scholar
Sturrock, R. F., James, C., James, E. R. & Webbe, G. (1980). Immunization of baboons (Papio anubis) against Schistosoma haematobium with irradiated cercariae or schistosomula. Transactions of the Royal Society of Tropical Medicine and Hygiene 74, 834–5.CrossRefGoogle ScholarPubMed
Webbe, G., James, C., Nelson, G. S., Ismail, M. M. & Shaw, J. R. (1979). Cross resistance between Schistosoma haematobium and S. mansoni in the baboon. Transactions of the Royal society of Tropical Medicine and Hygiene 73, 42–54.CrossRefGoogle ScholarPubMed
Webbe, G., James, C., Nelson, G. S., Smitmers, S. R. & Terry, R. J. (1976). Acquired resistance to Schistosoma haematobium in the baboon (Papio anubis) after cercarial exposure and adult worm transplantation. Annals of Tropical Medicine and Parasitology 70, 411–24.Google Scholar
Webbe, G., Sturrock, R. F., James, E. R. & James, C. (1982). Schistosom haenmatobium in the baboon (Papio anubis): effect of vaccination with irradiated larvae on subsequent infection with percutaneously applied cercariae. Transactions of the Royal Society of Tropical Medicine and Hygiene 76, 354–61.CrossRefGoogle Scholar